[TLX] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
31-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -66.47%
YoY- -79.78%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 1,607 1,667 1,818 195 49 49 49 304.25%
PBT -25,096 -25,690 -17,125 -10,524 -5,190 -3,928 -4,806 93.76%
Tax -6,795 -8,192 -6,756 1,884 -471 -471 -471 191.01%
NP -18,301 -17,497 -10,370 -8,640 -5,190 -3,457 -4,806 70.76%
Tax Rate - - - - - - - -
Total Cost 19,908 19,165 12,187 8,835 5,239 3,506 4,854 75.91%
Ratio Analysis
30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -1,138.83 -1,049.33 -570.54 -4,430.77 -10,638.53 -7,087.06 -9,850.62 -57.83%
Per Share
30/06/20 31/12/19 30/06/19 31/12/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.07 -0.07 -0.05 -0.04 -0.03 -0.02 -0.02 65.09%
EPS Diluted -0.07 -0.07 -0.05 -0.04 -0.03 -0.02 -0.02 65.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.